Status:
COMPLETED
Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules
Lead Sponsor:
hassan harby mohamed
Conditions:
Thyroid Nodule
Eligibility:
All Genders
15-60 years
Phase:
PHASE1
Brief Summary
Use of ethanol injection in treatment of cystic thyroid nodule
Detailed Description
Thyroid nodules are common discreet lesions in the parenchyma of thyroid gland which can either be palpated or made out during imaging like ultrasonography (USG).Clinically palpable thyroid nodules ha...
Eligibility Criteria
Inclusion
- Adult male or female patient with cystic thyroid nodule
- Presence of pressure symptoms or cosmetic problems
- Benign lesions confirmed by histopathological examination by FNAC.
- Serum levels of thyroid hormone thyrotropin, within normal limits.
Exclusion
- Nodules showing malignant features(ie, speculated margin, markedly hypo echoic, micro- or macro calcifications) at US
- solid thyroid nodule
- mixed thyroid nodule(cystic with solid component)
Key Trial Info
Start Date :
August 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03257930
Start Date
August 11 2017
End Date
January 1 2019
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71511